Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane®) in combination with gemcitabine in patients with metastatic breast cancer (N0531)

Vivek Roy, B. R. Laplant, G. G. Gross, C. L. Bane, F. M. Palmieri

Research output: Contribution to journalArticlepeer-review

103 Scopus citations

Fingerprint Dive into the research topics of 'Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane®) in combination with gemcitabine in patients with metastatic breast cancer (N0531)'. Together they form a unique fingerprint.

Medicine & Life Sciences